Answers are grounded in this paper and cite their sources.
Identifying the relevant chemical culprit is an important step in managing patients with photodistributed dermatitis, recalcitrant facial dermatitis or history of worsening after sun exposure. In such cases, recognizing and avoiding the responsible allergen is not merely helpful; it can be transformative, reducing recurrence and in some patients, enable near-complete disease control. The photopatch test (PPT) combines standard patch testing with ultraviolet (UV) A irradiation to detect photoallergic contact dermatitis (PACD), rather than photosensitivity caused by systemic medications.1 However, variation in methodology across centres and regions has long complicated the comparison of results,2,3 influencing diagnostic yield, false-positive rates and clinical interpretation. Ralph et al.,4 in this issue of the BJD, draw attention to the continued high prevalence of PACD to sunscreen chemicals and nonsteroidal anti-inflammatory drugs (NSAIDs) as well as practical aspects of the technique that may enhance the detection of allergens. This is particularly important because apparent positive PPT reactions may reflect weak irritant responses combined with a subclinical UVA effect3 or phototoxicity rather than true photoallergy.5
No takes yet. Share an insight, caveat, or question.
Boontaveeyuwat et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: